Larvol Delta - Blackstone-Life-Sciences-and-Anthos-Therapeutics-Announce-Novartis-has-Completed-the-Acquisition-of-Anthos-Therapeutics-in-a-Deal-Valued-at-up-to-31B-with-925M-Paid-Upfront

abelacimab (MAA868) - Novartis

https://www.businesswire.com/news/home/20250403148958/en/Blackstone-Life-Sciences-and-Anthos-Therapeutics-Announce-Novartis-has-Completed-the-Acquisition-of-Anthos-Therapeutics-in-a-Deal-Valued-at-up-to-%243.1B-with-%24925M-Paid-Upfront

Apr 3, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next